Search Results for 'Epo Biosimilar'

Epo Biosimilar published presentations and documents on DocSlides.

Challenges in demonstrating biosimilarity and interchangeability of biosimilar products

calandra-battersby
0 Slides

OMIC Group Biosimilars 2014. Hyderabad India. 27-...

The generic and biosimilar

alida-meadow
0 Slides

perspective. Warwick Smith. Director General BGMA...

PSHP President’s Update

myesha-ticknor
0 Slides

PSHP Annual Assembly. October 28, 2015. Matt Scol...

22 MayEMACHMPBWP2477132012Committee for Medicinal Products for Hum

carla
9 Slides

Adoption by CHMP for release for consultation24 Ma...

INSIGHTS INTO THE MARKET

summer
20 Slides

FOR INFLIXIMABTable of ContentsThe Evolving Landsc...

Nonproprietary Naming of Biological ProductsGuidance for IndustryUS De

anastasia
15 Slides

x0000x0000 x/Attxachexd /xBottxom x/BBoxx 3x014x33...

Improving Your Formulary and Denials Management

trinity
35 Slides

Zinkeng Asonganyi, PharmD. Director of Pharmacy Se...

Budget impact and cost-effectiveness of oncology

roxanne
14 Slides

biosimilars. Prof. dr. Steven Simoens. Health econ...

Medicare Part B Step Therapy Programs

elina
10 Slides

Page 1 of 10 UnitedHealthcare Medicare Advantag...

NEUPOGEN filgrastim

gelbero
5 Slides

GRANIX (tbo - filgrastim), NIVESTYM (filgrastim -...

Prescription Drug Resource Center

roberts
4 Slides

Generic Drug Substitution Laws May 3 , 2019 Compi...

1 Immunogenicity The key safety issue for biosimilars

gelbero
29 Slides

Prof. Ibrahim A. . Alsarra. Professor . of . Phar...

Challenges in Assessing Therapeutic Equivalence of

thomas
27 Slides

Nanosimilars. Beat . Flühmann. Global Lead NBCD ....

What is the value of Real-World Evidence for Biosimilars?

bitsy
82 Slides

Disclaimer. This panel is moderated by Dr. Delphin...

Category 1: Defining Terms

jasmine
76 Slides

Clue: . A biologic product with no clinically mean...

JMP for Biosimilars : Tools for Analytical Similarity

erica
26 Slides

Sept 16, 2015. W. Heath Rushing, . Adsurgo. LLC. ...

Regulatory aspects and review

mary
33 Slides

of EMA authorized . biosimilars. Session “Biosim...